Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Ensign Group | ENSG | Sep 19, 2024 | 152.24 | +0.82 |
The European Equity Fund | EEA | Sep 19, 2024 | 9.41 | +0.43 |
The First Bancshares | FBMS | Sep 19, 2024 | 33.98 | +3.69 |
The Gabelli Healthcare & Wellness Trust | GRX | Sep 19, 2024 | 11.11 | -0.13 |
The Gdl Fund | GDL | Sep 19, 2024 | 8.05 | +0.25 |
The Glimpse Group | VRAR | Sep 19, 2024 | 0.77 | -1.06 |
The Hackett Group | HCKT | Sep 19, 2024 | 26.88 | +1.13 |
The Hain Celestial Group | HAIN | Sep 19, 2024 | 7.87 | -1.99 |
The Hershey | HSY | Sep 19, 2024 | 195.52 | -1.07 |
The Herzfeld Caribbean Basin Fund | CUBA | Sep 19, 2024 | 2.29 | +2.23 |
The Honest Company | HNST | Sep 19, 2024 | 3.73 | -2.10 |
The Intergroup | INTG | Sep 19, 2024 | 16.21 | -0.80 |
The J.M Smucker Company | SJM | Sep 19, 2024 | 119.30 | -0.98 |
The Joint | JYNT | Sep 19, 2024 | 11.90 | +3.75 |
The Marygold Companies | MGLD | Sep 19, 2024 | 1.30 | -7.80 |
The ODP | ODP | Sep 19, 2024 | 29.74 | -0.17 |
The OLB Group | OLB | Sep 19, 2024 | 2.18 | 0.00 |
The Oncology Institute | TOI | Sep 19, 2024 | 0.29 | -1.77 |
The ONE Group Hospitality | STKS | Sep 19, 2024 | 3.71 | +4.21 |
The Pennant Group | PNTG | Sep 19, 2024 | 35.61 | +1.77 |
The Real Brokerage | REAX | Sep 19, 2024 | 5.78 | +3.77 |
The Real Estate Select Sector SPDR Fund | XLRE | Sep 19, 2024 | 44.76 | -0.25 |
The RealReal | REAL | Sep 19, 2024 | 3.26 | +1.56 |
The RMR Group A | RMR | Sep 19, 2024 | 25.63 | +1.95 |
The Shyft Group | SHYF | Sep 19, 2024 | 13.14 | +1.47 |
The Trade Desk A | TTD | Sep 19, 2024 | 110.14 | +1.96 |
The9 ADR | NCTY | Sep 19, 2024 | 6.60 | -2.19 |
TherapeuticsMD | TXMD | Sep 19, 2024 | 1.72 | +3.61 |
Theratechnologies | THTX | Sep 19, 2024 | 1.22 | +1.67 |
Theravance Biopharma | TBPH | Sep 19, 2024 | 8.21 | -0.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.